BD is proud to announce the availability of a valuable new service for FDA-regulated customers:
Automated Change Notification
for Difco™ and BBL™ brand culture media
and other microbiology and cell culture products
BD recognizes that you must provide certain types of change notification to regulatory agencies, as well as to your own customers. We have designed an automated notification system to assist you in meeting these requirements. This program will assist you in providing assurance toregulatory agencies that BD is notifying you about product changes. In addition, you will have greater assurance that these changes are taking place under our ISO-certified Quality Systems.
Customers may participate in this program by completing a Change Notification Agreement with BD. The application for this agreement allows you to select exactly the type of change and applicable product for which you wish to be notified. One or more contacts within your organization may be identified to be notified by mail, telephone or e-mail about these specific changes. The Change Notification Agreement will replace any and all preexisting agreements with BD concerning change notification, within the scope of microbiology products and tissue culture media manufactured in the U.S.
BD regards helping our customers meet their regulatory documentation needs as a serious responsibility and we appreciate your use of our products and services. BD facilities are FDA registered and certified to ISO 9000 Quality Systems/Standards.
To request a Change Notification Program packet, please e-mail us.
